Evidence map›Paper›PMID 38618164›Full record

ArticleIntegrative medicine (Encinitas, Calif.)2024

Time to Recognize and Address the Serious Arsenic Problem.

Joseph Pizzorno

Abstract readEditorial
In one paragraph

Article in Integrative medicine (Encinitas, Calif.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Pancreatic Exocrine Insufficiency Is Surprisingly Common.Integrative medicine (Encinitas, Calif.) · 2026
    Article
  2. Article
  3. Article
  4. Impact of Microplastics and Nanoplastics on Human Health.Integrative medicine (Encinitas, Calif.) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Joseph Pizzorno

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic low-level exposure to arsenic has a dose-dependent relationship with many chronic diseases. However, the typical arsenic safety standards used by governmental entities and laboratories appear inconsistent with current research. This editorial reviews the research and suggests that the random first-morning-urine total arsenic threshold for increased disease risk should be 5.0 μg/g creatinine or lower.

Identifiers

PMID38618164
PMCPMC11007617

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.